AnPac Bio-Medical Science Co., Ltd. (ANPC) 2021年年度报告「NASDAQ」.pdf

1、Table of Contents UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549 FORM 20-F(Mark One)REGISTRATION STATEMENT PURSUANT TO SECTION 12(b)OR 12(g)OF THE SECURITIES EXCHANGE ACT OF 1934ORANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal y

2、ear ended December 31,2021ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934ORSHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934Date of event requiring this shell company reportFor the transition period from to Commission

3、 file number:001-39137 AnPac Bio-Medical Science Co.,Ltd.(Exact name of Registrant as specified in its charter)N/A(Translation of Registrants name into English)British Virgin Islands(Jurisdiction of incorporation or organization)801 Bixing Street,Bihu CountyLishui,Zhejiang Province 323006 The People

4、s Republic of China(Address of principal executive offices)Chris Chang Yu,Co-Chairman and Co-Chief Executive OfficerTel:+86-21-51085515chris_801 Bixing Street,Bihu CountyLishui,Zhejiang Province 323006The Peoples Republic of China(Name,Telephone,E-mail and Address of Company Contact Person)Securitie

5、s registered or to be registered pursuant to Section 12(b)of the Act:Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which RegisteredAmerican depositary shares(each representing one Class A ordinary share,par value US$0.01 pershare)Class A ordinary share,par value US$0.01 per share*ANPC

6、NASDAQ Capital Market*Not for trading,but only in connection with the listing on the NASDAQ Capital Market of the American depositary shares.Securities registered or to be registered pursuant to Section 12(g)of the Act:NoneSecurities for which there is a reporting obligation pursuant to Section 15(d